Stock Analyses
Model-driven valuations for thousands of US-listed stocks, built from SEC EDGAR filings. Click any card to see the full analysis.
All sectors 6,479
Financial Services 1,900
Healthcare 1,116
Technology 1,079
Industrials 668
Consumer Cyclical 490
Basic Materials 337
Consumer Defensive 248
Communication Services 213
Utilities 183
Energy 165
Real Estate 80
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
A
Deeply overvalued
AGILENT TECHNOLOGIES, INC.
Price$156.47
Model IV$63.45
P/IV2.36
Premium +147%
Return to IV: -59.4%
Owner yield 2.7%
10-yr IRR -0.6% · steady
Market implies +16.0%/yr
vs model +4.7% · above model
AA
Deeply overvalued
Alcoa Corp
Price$44.43
Model IV$11.61
P/IV3.82
Premium +283%
Return to IV: -73.9%
Owner yield 0.2%
10-yr IRR -27.9% · steady
Market implies +22.1%/yr
vs model +2.5% · above model
AAAU
Valuation N/A
Goldman Sachs Physical Gold ETF
Price$43.14
Model IV—
P/IV—
AACB
Valuation N/A
Artius II Acquisition Inc.
Price$10.59
Model IV—
P/IV—
AACBR
Valuation N/A
Artius II Acquisition Inc.
Price$0.01
Model IV—
P/IV—
AACBU
Valuation N/A
AACBU
Price$10.70
Model IV—
P/IV—
AACG
Valuation N/A
ATA Creativity Global
Price$0.84
Model IV—
P/IV—
Market implies +21.5%/yr
vs model +4.8% · above model
AACI
Valuation N/A
Armada Acquisition Corp. III
Price$10.04
Model IV—
P/IV—
AACIU
Valuation N/A
Armada Acquisition Corp. III
Price$10.14
Model IV—
P/IV—
AACIW
Valuation N/A
Armada Acquisition Corp. III
Price$0.24
Model IV—
P/IV—
AACO
Valuation N/A
Abony Acquisition Corp. I
Price$9.99
Model IV—
P/IV—
AACOU
Valuation N/A
Abony Acquisition Corp. I
Price$10.06
Model IV—
P/IV—
AACOW
Valuation N/A
Abony Acquisition Corp. I
Price$0.44
Model IV—
P/IV—
AACP
Valuation N/A
Apogee Acquisition Corp
Price$10.06
Model IV—
P/IV—
AACPU
Valuation N/A
Apogee Acquisition Corp
Price$10.30
Model IV—
P/IV—
AAL
Deeply undervalued
American Airlines Group Inc.
Price$12.96
Model IV$21.77
P/IV0.67
Discount 40%
Return to IV: +68.0%
Owner yield 7.1%
10-yr IRR 14.8% · moderate
Market implies -1.6%/yr
vs model +8.0% · below model
AAME
Deeply undervalued
ATLANTIC AMERICAN CORP
Price$1.35
Model IV$2.38
P/IV0.91
Discount 43%
Return to IV: +76.1%
AAMI
Valuation N/A
Acadian Asset Management Inc.
Price$90.74
Model IV—
P/IV—
Market implies +37.9%/yr
vs model +2.0% · above model
AAOI
Valuation N/A
APPLIED OPTOELECTRONICS, INC.
Price$105.17
Model IV—
P/IV—
Market implies +46.5%/yr
vs model +21.2% · above model
AAON
Valuation N/A
AAON, INC.
Price$76.76
Model IV—
P/IV—
Market implies +18.1%/yr
vs model +28.2% · below model
AAP
Deeply overvalued
ADVANCE AUTO PARTS INC
Price$42.55
Model IV$14.14
P/IV4.26
Premium +201%
Return to IV: -66.8%
Market implies +18.3%/yr
vs model +3.0% · above model
AAPG
Valuation N/A
ASCENTAGE PHARMA GROUP INTERNATIONAL
Price$15.06
Model IV—
P/IV—
AAPL
Deeply overvalued
Apple Inc.
Price$336.13
Model IV$115.28
P/IV2.71
Premium +192%
Return to IV: -65.7%
Owner yield 2.0%
10-yr IRR -1.1% · moderate
Market implies +22.1%/yr
vs model +8.8% · above model
AARD
Valuation N/A
Aardvark Therapeutics, Inc.
Price$5.38
Model IV—
P/IV—
AAT
Fairly valued
American Assets Trust, Inc.
Price$21.95
Model IV$25.00
P/IV0.93
Discount 12%
Return to IV: +13.9%
AAUC
Valuation N/A
Allied Gold Corp
Price$22.91
Model IV—
P/IV—
AB
Fairly valued
ALLIANCEBERNSTEIN HOLDING L.P.
Price$36.31
Model IV$39.78
P/IV0.93
Discount 9%
Return to IV: +9.6%
Market implies -5.3%/yr
vs model -1.9% · below model
ABAT
Valuation N/A
AMERICAN BATTERY TECHNOLOGY Co
Price$2.18
Model IV—
P/IV—
Market implies +55.3%/yr
vs model +5.0% · above model
ABBV
Overvalued
AbbVie Inc.
Price$263.96
Model IV$208.02
P/IV1.24
Premium +27%
Return to IV: -21.2%
Owner yield 3.9%
10-yr IRR 3.8% · steady
Market implies +7.0%/yr
vs model +4.5% · in line
ABCB
Deeply overvalued
Ameris Bancorp
Price$83.50
Model IV$64.14
P/IV1.31
Premium +30%
Return to IV: -23.2%
ABCL
Valuation N/A
AbCellera Biologics Inc.
Price$12.63
Model IV—
P/IV—
Market implies +111.1%/yr
vs model +2.0% · above model
ABEO
Valuation N/A
ABEONA THERAPEUTICS INC.
Price$5.57
Model IV—
P/IV—
Market implies +52.7%/yr
vs model +18.0% · above model
ABEV
Valuation N/A
AMBEV S.A.
Price$2.94
Model IV—
P/IV—
ABG
Deeply undervalued
ASBURY AUTOMOTIVE GROUP INC
Price$183.06
Model IV$957.18
P/IV0.20
Discount 81%
Return to IV: +422.9%
Owner yield 15.0%
10-yr IRR 34.2% · grower
Market implies -12.4%/yr
vs model +14.4% · below model
ABLV
Deeply overvalued
Able View Global Inc.
Price$0.90
Model IV$0.40
P/IV2.75
Premium +125%
Return to IV: -55.6%
Market implies +10.9%/yr
vs model +3.0% · above model
ABLVW
Valuation N/A
Able View Global Inc.
Price$0.01
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +0.5% · below model
ABM
Overvalued
ABM INDUSTRIES INC /DE/
Price$49.91
Model IV$39.38
P/IV1.28
Premium +27%
Return to IV: -21.1%
Owner yield 4.4%
10-yr IRR 9.3% · moderate
Market implies +11.1%/yr
vs model +9.8% · in line
ABNB
Deeply overvalued
Airbnb, Inc.
Price$166.22
Model IV$127.32
P/IV1.05
Premium +31%
Return to IV: -23.4%
Market implies +17.1%/yr
vs model +17.3% · in line
ABOS
Valuation N/A
Acumen Pharmaceuticals, Inc.
Price$2.65
Model IV—
P/IV—
ABR
Valuation N/A
ARBOR REALTY TRUST INC
Price$4.28
Model IV—
P/IV—
ABSI
Valuation N/A
Absci Corp
Price$9.65
Model IV—
P/IV—
Market implies +115.9%/yr
vs model +2.0% · above model
ABT
Fairly valued
ABBOTT LABORATORIES
Price$102.61
Model IV$104.52
P/IV0.82
Discount 2%
Return to IV: +1.9%
Owner yield 3.5%
10-yr IRR 2.0% · steady
Market implies +3.3%/yr
vs model +4.1% · in line
ABTC
Valuation N/A
American Bitcoin Corp.
Price$10.10
Model IV—
P/IV—
Market implies +60.4%/yr
vs model +50.0% · above model
ABTS
Deeply undervalued
Abits Group Inc
Price$1.30
Model IV$3.57
P/IV0.23
Discount 64%
Return to IV: +174.6%
Market implies -16.6%/yr
vs model +46.0% · below model
ABUS
Valuation N/A
Arbutus Biopharma Corp
Price$5.06
Model IV—
P/IV—
Market implies +84.2%/yr
vs model +2.0% · above model
ABVC
Valuation N/A
ABVC BIOPHARMA, INC.
Price$1.16
Model IV—
P/IV—
Market implies +64.2%/yr
vs model +2.0% · above model
ABVE
Valuation N/A
Above Food Ingredients Inc.
Price$0.11
Model IV—
P/IV—
ABVEW
Valuation N/A
ABVEW
Price$0.02
Model IV—
P/IV—
ABVX
Valuation N/A
Abivax S.A.
Price$105.04
Model IV—
P/IV—
ABX
Deeply overvalued
Abacus Global Management, Inc.
Price$8.77
Model IV$2.05
P/IV4.39
Premium +329%
Return to IV: -76.7%
Market implies +18.8%/yr
vs model +15.0% · above model
ABXL
Deeply overvalued
Abacus Global Management, Inc.
Price$25.42
Model IV$6.93
P/IV3.68
Premium +267%
Return to IV: -72.7%
Market implies +16.2%/yr
vs model +50.0% · below model
ACA
Deeply overvalued
Arcosa, Inc.
Price$145.15
Model IV$46.33
P/IV2.74
Premium +213%
Return to IV: -68.1%
Owner yield 2.6%
10-yr IRR 1.1% · moderate
Market implies +22.8%/yr
vs model +8.2% · above model
ACAA
Valuation N/A
Averin Capital Acquisition Corp.
Price$9.99
Model IV—
P/IV—
ACAAU
Valuation N/A
Averin Capital Acquisition Corp.
Price$10.16
Model IV—
P/IV—
ACAAW
Valuation N/A
Averin Capital Acquisition Corp.
Price$0.76
Model IV—
P/IV—
ACAD
Deeply overvalued
ACADIA PHARMACEUTICALS INC
Price$27.29
Model IV$10.33
P/IV2.10
Premium +164%
Return to IV: -62.1%
Market implies +27.4%/yr
vs model +18.4% · above model
ACB
Valuation N/A
AURORA CANNABIS INC
Price$3.87
Model IV—
P/IV—
ACCL
Overvalued
Acco Group Holdings Ltd
Price$2.83
Model IV$2.39
P/IV0.63
Premium +19%
Return to IV: -15.7%
Owner yield 3.2%
10-yr IRR 6.7% · grower
Market implies +8.4%/yr
vs model +12.2% · below model
ACCO
Fairly valued
ACCO BRANDS Corp
Price$4.17
Model IV$4.58
P/IV0.86
Discount 9%
Return to IV: +9.9%
Market implies -5.5%/yr
vs model -1.6% · below model
ACCS
Fairly valued
ACCESS Newswire Inc.
Price$4.98
Model IV$5.66
P/IV1.14
Discount 12%
Return to IV: +13.7%
Market implies -11.4%/yr
vs model +2.0% · below model